Effect of glutamine on glucose metabolism in children with Duchenne muscular dystrophy.
暂无分享,去创建一个
F. Gottrand | A. Denjean | D. Darmaun | C. Alberti | J. Cuisset | R. Hankard | A. D. de Luca | E. Mok | G. Letellier
[1] J. Settleman,et al. Modulation of Rho GTPase Signaling Regulates a Switch between Adipogenesis and Myogenesis , 2003, Cell.
[2] N. Mauras,et al. Acute depletion of plasma glutamine increases leucine oxidation in prednisone-treated humans. , 2007, Clinical nutrition.
[3] J. Pachl,et al. Parenterally administered dipeptide alanyl-glutamine prevents worsening of insulin sensitivity in multiple-trauma patients , 2006, Critical care medicine.
[4] F. Gottrand,et al. Resting Energy Expenditure and Energy Substrate Utilization in Children with Duchenne Muscular Dystrophy , 1996, Pediatric Research.
[5] M. Haymond,et al. Effect of glutamine on leucine metabolism in humans. , 1996, The American journal of physiology.
[6] N. Mauras,et al. Corticosteroids increase glutamine utilization in human splanchnic bed. , 2008, American journal of physiology. Gastrointestinal and liver physiology.
[7] D. Kipnis,et al. Measurement of “True” Glucose Production Rates in Infancy and Childhood with 6,6-Dideuteroglucose , 1977, Diabetes.
[8] O. Bacquer,et al. Acute Effects of Intravenous Glutamine Supplementation on Protein Metabolism in Very Low Birth Weight Infants: A Stable Isotope Study , 2002, Pediatric Research.
[9] M. Haymond,et al. Role of Glutamine as a Glucose Precursor in Fasting Humans , 1997, Diabetes.
[10] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[11] M. Goddeeris,et al. Sarcoglycan Complex , 2009, The Journal of Biological Chemistry.
[12] E. Levy,et al. Distribution of fasting plasma insulin, free fatty acids, and glucose concentrations and of homeostasis model assessment of insulin resistance in a representative sample of Quebec children and adolescents. , 2003, Clinical chemistry.
[13] Á. Robles,et al. The effect of l-alanyl-l-glutamine dipeptide supplemented total parenteral nutrition on infectious morbidity and insulin sensitivity in critically ill patients* , 2011, Critical care medicine.
[14] M. Stumvoll,et al. Regulation of gluconeogenesis by glutamine in normal postabsorptive humans. , 1997, The American journal of physiology.
[15] M. Haymond,et al. Oral Glutamine Slows Down Whole Body Protein Breakdown in Duchenne Muscular Dystrophy , 1998, Pediatric Research.
[16] G F Cahill,et al. Starvation in man. , 1970, The New England journal of medicine.
[17] R. Hankard,et al. L-Glutamine Administration Reduces Oxidized Glutathione and MAP Kinase Signaling in Dystrophic Muscle of mdx Mice , 2008, Pediatric Research.
[18] T J Cole,et al. Body Mass Index variations: centiles from birth to 87 years. , 1991, European journal of clinical nutrition.
[19] N. Mauras,et al. Is glutamine a 'conditionally essential' amino acid in Duchenne muscular dystrophy? , 1999, Clinical nutrition.
[20] C. Mulvey,et al. Expression of the skeletal muscle dystrophin-dystroglycan complex and syntrophin-nitric oxide synthase complex is severely affected in the type 2 diabetic Goto-Kakizaki rat. , 2005, European journal of cell biology.
[21] F. Gottrand,et al. Lack of Functional Benefit with Glutamine versus Placebo in Duchenne Muscular Dystrophy: A Randomized Crossover Trial , 2009, PloS one.
[22] S. Kurtoğlu,et al. Homeostasis Model Assessment Is More Reliable Than the Fasting Glucose/Insulin Ratio and Quantitative Insulin Sensitivity Check Index for Assessing Insulin Resistance Among Obese Children and Adolescents , 2005, Pediatrics.
[23] H. Nishio,et al. Glucose, free fatty acid and ketone body metabolism in duchenne muscular dystrophy , 1990, Brain and Development.
[24] M. Stumvoll,et al. Glutamine: a major gluconeogenic precursor and vehicle for interorgan carbon transport in man. , 1995, The Journal of clinical investigation.
[25] F. Gottrand,et al. Oral glutamine and amino acid supplementation inhibit whole-body protein degradation in children with Duchenne muscular dystrophy. , 2006, The American journal of clinical nutrition.
[26] R. DeFronzo,et al. Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.
[27] F. Gottrand,et al. Estimating body composition in children with Duchenne muscular dystrophy: comparison of bioelectrical impedance analysis and skinfold-thickness measurement. , 2006, The American journal of clinical nutrition.
[28] M. Haymond,et al. Muscle wasting and carbohydrate homeostasis in Duchenne muscular dystrophy , 1978, Neurology.
[29] Myriam Nenquin,et al. Nutrient Control of Insulin Secretion in Isolated Normal Human Islets , 2006, Diabetes.
[30] M. Haymond,et al. Response of glutamine metabolism to exogenous glutamine in humans. , 1995, The American journal of physiology.
[31] J. Holst,et al. Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects. , 2009, The American journal of clinical nutrition.